Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: TNF

Intestinal alterations in patients with Parkinson’s disease

Presented By
Dr Gabriele Bellini, University of Pisa, Italy
Conference
EAN 2022

22 August, 2022 16:12

New insights into psoriasis comorbidity

Presented By
Prof. Joel Gelfand, University of Pennsylvania, USA
Conference
AAD 2022

17 May, 2022 12:12

Comparable safety profiles of biological therapies in elderly patients with IBD

Presented By
Dr Gustavo Drügg Hahn, McGill University Health Center, Canada
Conference
ECCO 2022

12 April, 2022 17:22

Stopping infliximab but not antimetabolites leads to more relapses in Crohn’s disease

Presented By
Prof. Edouard Louis, University Hospital Liège, Belgium
Trial
Phase 4, SPARE
Conference
ECCO 2022

12 April, 2022 16:55

Anti-TNFs versus vedolizumab and ustekinumab in Crohn’s disease

Presented By
Dr Neeraj Narula, McMaster University, Canada
Conference
ECCO 2022

12 April, 2022 16:46

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By
Prof. Remo Panaccione , University of Calgary, Canada
Conference
ECCO 2022

12 April, 2022 16:44

Subcutaneous infliximab versus subcutaneous vedolizumab in IBD

Presented By
Prof. Laurent Peyrin-Biroulet, Nancy University Hospital, France
Conference
ECCO 2022

12 April, 2022 16:41

Vedolizumab outperforms anti-TNF in biologic-naïve ulcerative colitis

Presented By
Dr Bernd Bokemeyer, University Hospital Schleswig-Holstein, Germany
Trial
VEDO-IBD
Conference
ECCO 2022

12 April, 2022 16:37

Guselkumab plus golimumab promising combination for ulcerative colitis

Presented By
Prof. Bruce Sands, Mount Sinai School of Medicine, NY, USA
Trial
Phase 2, VEGA
Conference
ECCO 2022

12 April, 2022 16:10

TNF inhibitor for immune-mediated inflammatory disease doubles the risk of paradoxical psoriasis

Presented By
Dr Nikolai Loft, Copenhagen University Hospital, Denmark
Conference
PFGC 2021

3 February, 2022 15:08

The Yin and Yang of opposing vectors: an explanation for side effects of biologics

Presented By
Prof. Curdin Conrad, Lausanne University Hospital, Switzerland
Conference
PFGC 2021

3 February, 2022 11:07

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By
Dr Charlie Bridgewood, University of Leeds, UK
Conference
PFGC 2021

3 February, 2022 10:51

TNF blockers likely beneficial for psoriatic patients with COVID-19

Presented By
Prof. Catherine Smith, King’s College London, UK
Trial
PsoProtect
Conference
PFG 2021

2 February, 2022 15:42

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021

2 February, 2022 15:22

Why antipsychotics cause weight gain

Presented By
Prof. Louise Gallagher, University of Dublin, Ireland
Conference
ECNP 2021

26 November, 2021 11:18

Existing and upcoming small molecules in psoriasis

Presented By
Dr Enikö Sonkoly , Karolinska University Hospital, Sweden
Trial
POETYK PSO; PSOARING
Conference
EADV 2021

18 November, 2021 13:19

Treating psoriasis during pregnancies

Presented By
Prof. Mahira Hamdy El Sayed, Ain Shams University, Egypt
Conference
EADV 2021

18 November, 2021 13:18

Grand debate: Is psoriasis a systemic or skin-only disease?

Presented By
Prof. Brian Kirby & Prof. Stefano Piaserico
Conference
EADV 2021

18 November, 2021 13:14

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By
Dr Akhil Sood, University of Texas Medical Branch, USA
Conference
ACR 2020

18 January, 2021 10:57

Poor disease control: a risk factor for severe COVID-19

Presented By
Prof. Rebecca Grainger, University of Otago, New Zealand
Trial
COVID-19 Global Rheumatology Alliance Registry
Conference
ACR 2020

18 January, 2021 10:57

E-cigarettes: A source of chronic lung inflammation

Presented By
Prof. Shama Ahmad, University of Alabama at Birmingham, USA
Conference
ERS 2020

29 October, 2020 19:08

COVID-19 and inflammatory rheumatic disease: some key issues

Presented By
Prof. G. Burmester, Charité University Hospital, Germany
Conference
EULAR 2020

14 August, 2020 15:06

AxSpA real-life remission rates higher on biologics

Presented By
Dr Charlotte Baert, Saint Luc University Hospital, Belgium
Conference
EULAR 2020

14 August, 2020 10:24

TNF-α inhibitors improve bone mineral density in AS patients

Presented By
Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands
Conference
EULAR 2020

14 August, 2020 10:13

Psoriasis therapy for children and pregnancies

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA
Trial
CRIB, CADMUS, IXORA-PEDS
Conference
AAD 2020

6 August, 2020 08:03

Can gene expression help to pick the right biologic to treat psoriasis in cancer patients?

Presented By
Dr Nikolai Klebanov , Brigham and Women’s Hospital, USA
Conference
AAD 2020

6 August, 2020 07:01

Experimental model for limitations of haematopoietic stem cells propagation

Presented By
Dr Jennifer Myers SanMiguel, The Jackson Laboratory, USA
Conference
ASH 2019

5 March, 2020 14:47

Lowest risk of infection after therapy with an IL-12/IL-23 blocker

Presented By
Dr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA
Trial
Cohort study
Conference
ACR 2019

4 February, 2020 23:42

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019

4 February, 2020 23:12

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By
Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK
Conference
ACR 2019

4 February, 2020 20:10

TNFi for RA during pregnancy – to stop or not to stop?

Presented By
Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany
Conference
ACR 2019

4 February, 2020 10:16

Biologics: increasingly used in paediatric dermatology

Presented By
Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands
Conference
EADV 2019

9 December, 2019 15:16

ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker

Presented By
Prof. Diamant Thaçi, University of Lübeck, Germany
Trial
ESPRIT
Conference
EADV 2019

9 October, 2019 19:23

Certolizumab pegol efficacious for head and neck psoriasis

Presented By
Prof. Peter van de Kerkhof, Radboud University, the Netherlands
Trial
Phase 3, CIMPASI-1 and CIMPASI-2
Conference
EADV 2019

9 October, 2019 15:02

Biologicals beyond TNF blockade

Presented By
Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland
Conference
WCD 2019

26 August, 2019 11:11

Advances in target-oriented therapy: psoriatic arthritis

Presented By
Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland
Trial
ECLIPSA, TICOPA
Conference
SPIN 2019

21 June, 2019 23:48

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By
Prof. Kristian Reich, Georg-August-University Göttingen, Germany
Trial
ECLIPSE
Conference
SPIN 2019

21 June, 2019 18:23

Small molecules, apremilast, and TYK2

Presented By
Prof. Richard Langley, Dalhousie University, Canada
Trial
ESTEEM, PALACE, LIBERATE
Conference
SPIN 2019

21 June, 2019 09:45

Molecular effects of ustekinumab

Trial
Phase 3, UNITI
Conference
ECCO 2019

9 May, 2019 19:47

Gene expression signature predicts non-response

Trial
ACT1, PURSUIT-SC, PROgECT, PURSUIT-J, UNITI
Conference
ECCO 2019

9 May, 2019 18:48

JAK inhibitors: a new therapeutic tool for dermatologists

Presented By
Prof. Brett King, Yale School of Medicine, USA
Conference
AAD 2019

19 April, 2019 20:08

Psoriasis and Biologics: The Beat Goes On

Presented By
Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA
Conference
AAD 2019

19 April, 2019 14:06
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy